Your browser doesn't support javascript.
loading
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
Paskeh, Mahshid Deldar Abad; Ghadyani, Fatemeh; Hashemi, Mehrdad; Abbaspour, Alireza; Zabolian, Amirhossein; Javanshir, Salar; Razzazan, Mehrnaz; Mirzaei, Sepideh; Entezari, Maliheh; Goharrizi, Mohammad Ali Shekhi Beig; Salimimoghadam, Shokooh; Aref, Amir Reza; Kalbasi, Alireza; Rajabi, Romina; Rashidi, Mohsen; Taheriazam, Afshin; Sethi, Gautam.
Affiliation
  • Paskeh MDA; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Ghadyani F; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Hashemi M; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Abbaspour A; Cellular and Molecular Research Center,Qazvin University of Medical Sciences, Qazvin, Iran.
  • Zabolian A; Resident of department of Orthopedics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Javanshir S; Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Razzazan M; Medical Student, Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran.
  • Mirzaei S; Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran.
  • Entezari M; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Goharrizi MASB; Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Salimimoghadam S; Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Aref AR; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Translational Sciences, Xsphera Biosciences Inc. 6, Tide Street, Boston, MA 02210, USA.
  • Kalbasi A; Department of Pharmacy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Rajabi R; Faculty of Veterinary Medicine, Islamic Azad University, Science and Research Branch, Tehran, Iran. Electronic address: rajabiromina74@gmail.com.
  • Rashidi M; Department Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; The Health of Plant and Livestock Products Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: dr.mohsenrashidi@yahoo.com.
  • Taheriazam A; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Department of Orthopedics, Faculty of medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: a.taheriazam@iautmu.ac.
  • Sethi G; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore; NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore. Electronic address: phcgs@nus.edu.sg.
Pharmacol Res ; 187: 106553, 2023 01.
Article in En | MEDLINE | ID: mdl-36400343
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: Iran
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: Iran